Probiotics - Scope and promise in inflammatory bowel disease

Israel Medical Association Journal

Volumn 4, Issue 5, 2002, Pages 353-356

  Chermesh, Irit ^a   Eliakim, Rami ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Crohn's disease; Inflammatory bowel disease; Probiotics; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; GENTAMICIN; LACTASE; MESALAZINE; PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CROHN DISEASE; DIARRHEA; DIGESTION; DISEASE SEVERITY; DRUG MECHANISM; DRUG SCREENING; ENTERITIS; ESCHERICHIA COLI; FECES ANALYSIS; FOOD MICROBIOTECHNOLOGY; FUNGEMIA; HUMAN; IMMUNE RESPONSE; INFANT DISEASE; INTESTINE FLORA; LACTIC ACIDOSIS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; LACTOSE INTOLERANCE; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; RECURRENT DISEASE; REVIEW; SACCHAROMYCES BOULARDII; TRAVELLER DIARRHEA; ULCERATIVE COLITIS;

HUMANS; INFLAMMATORY BOWEL DISEASES; PROBIOTICS;

EID: 0036247387     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Crohn's disease
2. Ulcerative colitis disease
3. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn disease
4. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique
5. Double-blind, placebo controlled trial of metronidazole in Crohn's disease
6. Treatment of fistulizing Crohn's disease
7. Antibiotic treatment in inflammatory bowel disease: Rifaximin, a new possible approach
8. Interleukin-10-deficient mice develop chronic enterocolitis
9. Insights into the pathogenesis of inflammatory bowel disease provided by new rodent models of spontaneous colitis
10. Probiotics, the other half of the antibiotic story
11. Probiotics, prebiotics and symbiotics - Approaching a definition
12. Lactobacilli to prevent traveler's diarrhea?
13. Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in the stable phase of Crohn's disease with special respect to chronic diarrhea - A pilot study
14. Non pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
15. In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings
16. Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk
17. Effect of yogurt on symptoms and kinetics of hydrogen production in lactose-malabsorbing children
18. Essais Cliniques contrôlés en double insu de Ultralevure lyophylisée
19. Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: A prospective study
20. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain
21. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
22. Oral bacteriotherapy for viral gastroenteritis
23. Effect of a lactobacilli preparation on traveler's diarrhea. A randomized, double blind clinical trial
24. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers
25. Intestinal IgA: Novel views on its function in the defense of the largest mucosal surface
26. Functional food science and gastrointestinal physiology and function
27. Probiotics reinforce mucosal degradation of antigens: Implications for therapeutic use of probiotics
28. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children
29. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid induced colitis in the rat
30. Fecal beta-D-galactosidase production and bifidobacteria are decreased in Crohn's disease
31. Pouchitis: Result of microbial imbalance?
32. Lactobacillus species prevents colitis in interleukin 10 gene deficient mice
33. The effects of Lactobacillus strains and oat fiber on methotrexate induced enterocolitis in rats
34. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG
35. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double blind, placebo-controlled trial
36. Impact on the composition of the faecal flora by a new probiotic preparation: Preliminary data on maintenance treatment of patients with ulcerative colitis
37. Double blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
38. Micro-organisms administered in the benefit of the host: Myth and facts
39. Impact écologique de antibiothérapie
40. Fungemia with Saccharomyces boulardii in a 1-year-old girl with protracted diarrhea